Elucidation of Lyme arthritis

Nature Reviews Immunology

Volumn 4, Issue 2, 2004, Pages 143-152

  Steere, Allen C ^a   Glickstein, Lisa ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC THERAPY; AUTOIMMUNITY; BORRELIA BURGDORFERI; CHRONIC INFLAMMATION; IMMUNOPATHOGENESIS; INFLAMMATION; JUVENILE RHEUMATOID ARTHRITIS; LYME DISEASE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SPIROCHETE; SYNOVITIS; TICK BORNE DISEASE; UNITED STATES;

EID: 1142310887     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1267     Document Type: Review

References (117)

1. Steere, A. C. et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 20, 7-17 (1977).
2. Steere, A. C. et al. Erythema chronicum migrans and Lyme arthritis: the enlarging clinical spectrum. Ann. Intern. Med. 86, 685-698 (1977).
3. Steere, A. C., Broderick, T. F. & Malawista, S. E. Erythema chronicum migrans and Lyme arthritis: epidemiologic evidence for a tick vector. Amer. J. Epidemiol. 108, 312-321 (1978).
4. Afzelius, A. Erythema chronicum migrans. Acta Derm. Venereol. (Stockh.) 2, 120-125 (1921).
5. Burgdorfer, W. et al. Lyme disease - a tick-borne spirochetosis? Science 216, 1317-1319 (1982).
6. Steere, A. C. et al. The spirochetal etiology of Lyme disease. N. Engl. J. Med. 308, 733-740 (1983).
7. Baranton, G. et al. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Internatl J. Systematic Bacteriol. 42, 378-383 (1992).
8. Steere, A. C., Schoen, R. T. & Taylor, E. The clinical evolution of Lyme arthritis. Ann. Intern. Med. 107, 725-731 (1987). This long-term longitudinal study presents the natural history of Lyme arthritis in patients before the use of antibiotics for treatment of the disorder.
9. Jaulhac, B. et al. Direct molecular typing of Borrelia burgdorferi sensu lato species in synovial samples from patients with Lyme arthritis. J. Clin. Microbiol. 38, 1895-1900 (2000).
10. Lunemann, J. D. et al. Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of Lyme borreliosis. J. Clin. Microbiol. 39, 1130-1133 (2001).
11. de Silva, A. M. & Fikrig, E. Arthropod- and host-specific gene expression by Borrelia burgdorferi. J. Clin. Invest. 100, S3-S5 (1997).
12. Montgomery, R. R., Malawista, S. E., Feen, K. J. M. & Bockenstedt, L. K. Direct demonstration of antigenic substitution of Borrellia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease. J. Exp. Med. 183, 261-269 (1996).
13. Schwan, T. G., Piesman, J., Golde, W. T., Dolan, M. C. & Rosa, P. A. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl Acad. Sci. USA 92, 2909-2913 (1995).
14. Coleman, J. L. et al. Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 89, 1111-1119 (1997).
15. Seinost, G. et al. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect. Immun. 67, 3518-3524 (1999).
16. Zhang, J.-R. & Norris, S. J. Genetic variation of the Borrelia burgdorferi gene vlsE involves cassettes-specific, segmental gene conversation. Infect. Immun. 66, 3698-3704 (1998).
17. Coburn, J., Chege, W., Magoun, L., Bodary, S. C. & Leong, J. M. Characterization of a candidate Borrelia burgdorferi β3-chain integrin ligand identified using a phage display library. Mol. Microbiol. 34, 926-940 (1999).
18. Parveen, N. & Leong, J. M. Identification of a candidate glycosaminoglycan-binding adhesin of the Lyme disease spirochete Borrelia burgdorferi. Mol. Microbiol. 35, 1220-1234 (2000).
19. Probert, W. S. & Johnson, B. J. B. Identification of a 47kDa fibronectin-binding protein expressed by Borrelia burgdorferi isolate B32. Mol. Microbiol. 30, 1003-1015 (1998).
20. Johnson, B. A., Haines, G. K., Harlow, L. A. & Koch, A. E. Adhesion molecule expression in human synovial tissue. Arthritis Rheum. 36, 137-146 (1993).
21. Guo, B. P., Brown, E. L., Dorward, D. W., Rosenberg, L. C. & Hook, M. Decorin-binding adhesins from Borrelia burgdorferi. Mol. Microbiol. 30, 711-723 (1998).
22. Duray, P. H. The surgical pathology of human Lyme disease: an enlarging picture. Amer. J. Surg. Pathol. 11, 47-60 (1987).
23. Hefty, P. S., Jolliff, S. E., Caimano, M. J., Wikel, S. K. & Akins, D. R. Changes in temporal and spatial patterns of outer surface lipoprotein expression generate population heterogeneity and antigenic diversity in the Lyme disease spirochete, Borrelia burgdorferi. Infect. Immun. 70, 3468-3478 (2002).
24. Muellegger, R. R. et al. Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans. J. Invest. Dermatol. 115, 1115-1123 (2000).
25. Glickstein, L. et al. Inflammatory cytokine production predominates in early Lyme disease in patients with erythema migrans. Infect. Immun. 71,6051-6053 (2003).
26. Salazar, J. C., et al. Coevolution of markers of innate and adaptive immunity in skin and peripheral blood of patients with erythema migrans. J. Immunol. 171, 2660-2670 (2003).
27. Vaz, A. et al. Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease. Infect. Immun. 69, 7437-7444 (2001).
28. Akin, E., McHugh, G. L., Flavell, R. A., Fikrig, E. & Steere, A. C. The immunoglobin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect. Immun. 67, 173-181 (1999). This study gives the most complete analysis of the correlation of humoral immunity to outer-surface protein A (OspA) with treatment-resistant Lyme arthritis.
29. Nocton, J. J. et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid in Lyme arthritis. N. Engl. J. Med. 330, 229-234 (1994). This analysis of joint fluid samples from patients with Lyme arthritis shows that Borrelia burgdorferi DNA is usually present before antibiotic treatment, but not after ≥2 months of oral therapy or ≥1 month of intravenous therapy.
30. Hardin, J. A., Steere, A. C. & Malawista, S. E. Immune complexes and the evolution of Lyme arthritis: dissemination and localization of abnormal C1q binding activity. N. Engl. J. Med. 301, 1358-1363 (1979).
31. Steere, A. C., Hardin, J. A., Ruddy, S., Mummaw, J. G. & Malawista, S. E. Lyme arthritis: correlation of serum and cryoglobulin IgM with activity, and serum IgG with remission. Arthritis Rheum. 22, 471-483 (1979).
32. Beck, G., Benach, J. L. & Habicht, G. S. Isolation of interleukin 1 from joint fluids of patients with Lyme disease. J. Rheumatol. 16, 800-806 (1989).
33. Miller, L. C. et al. Balance of synovial fluid IL-1β and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 341, 146-148 (1993).
34. Yin, Z. et al. T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines. Arthritis Rheum. 40, 69-79 (1997).
35. Yssel, H. et al. Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J. Exp. Med. 174, 593-601 (1991).
36. Gross, D. M., Steere, A. C. & Huber, B. T. T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J. Immunol. 160, 1022-1028 (1998).
37. Roessner, K. et al. High expression of Fas ligand by synovial fluid-derived γδ T cells in Lyme arthritis. J. Immunol. 170, 2702-2710 (2003).
38. Glatzel, A. et al. The responsiveness of human Vδ1 γδ T cells to Borrelia burgdorferi is largely restricted to synovial-fluid cells from patients with Lyme arthritis. J. Infect. Dis. 186, 1043-1046 (2002).
39. Dressler, F., Whalen, J. A., Reinhardt, B. N. & Steere, A. C. Western blotting in the serodiagnosis of Lyme disease. J. Infect. Dis. 167,392-400 (1993).
40. Steere, A. C. et al. Treatment of Lyme arthritis. Arthritis Rheum. 37, 878-888 (1994).
41. Barthold, S. W. et al. Experimental Lyme arthritis in rats infected with Borrelia burgdorferi. J. Infect. Dis. 157, 842-846 (1988).
42. Schaible, U. E. et al. The severe combined immunodeficiency (scid) mouse: a laboratory model for the analysis of Lyme arthritis and carditis. J. Exp. Med. 170, 1427-1432 (1989).
43. Barthold, S. W., Beck, D. S., Hansen, G. M., Terwilliger, G. A. & Moody, K. D. Lyme borreliosis in selected strains and ages of laboratory mice. J. Infect. Dis. 162, 133-138 (1990).
44. Ma, Y. et al. Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect. Immun. 68, 161-168 (1998).
45. Wooten, R. M. et al. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J. Immunol. 168, 348-355 (2002).
46. Alexopoulou, L. et al. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nature Med. 8, 878-884 (2002).
47. Jacchied, S. G., et al. Structural study of binding of flagellin by Toll-like receptor 5. J. Bacteriol. 185, 4243-4247 (2003).
48. Talkington, J. & Nickell, S. P. Role of Fcγ receptors in triggering host cell activation and cytokine release by Borrelia burgdorferi. Infect. Immun. 69, 413-419 (2001).
49. Montgomery, R. R. & Malawista, S. E. Entry of Borrelia burgdorferi into macrophages is end-on and leads to degradation in lysosomes. Infect. Immun. 64, 2867-2872 (1996).
50. Rittig, M. G. et al. Coiling phagocytosis is the preferential phagocytic mechanism for Borrelia burgdorferi. Infect. Immun. 60, 4205-4212 (1992).
51. Modolell, M., Schaible, U. E., Rittig, M. & Simon, M. M. Killing of Borrelia burgdorferi by macrophages is dependent on oxygen radicals and nitric oxide and can be enhanced by antibodies to outer surface proteins of the spirochete. Immunol. Letters 40, 139-146 (1994).
52. Defosse D. L. & Johnson, R. C. In vitro and in vivo induction of tumor necrosis factor α by Borrelia burgdorferi. Infect. Immun. 60, 1109-1113 (1992).
53. Anguita, J. et al. Cyclooxygenase 2 activity modulates the severity of murine Lyme arthritis. FEMS Immunol. Med. Microbiol. 34, 187-191 (2002).
54. Gebbia, J. A., Coleman, J. L. & Benach, J. L. Borrelia spirochetes upregulate release and activation of matrix metalloproteinase gelatinase B (MMP-9) and collagenase 1 (MMP-1) in human cells. Infect. Immun. 69, 456-462 (2001).
55. Brown, C. R., Blaho, V. A. & Loiacono, C. M. Susceptibility to experimental Lyme arthritis correlates with KC and monocytes chemoattractant protein-1 in joints and requires neutrophil recruitment via CXCR21. J. Immun. 171, 893-901 (2003).
56. Weis, J. J. et al. Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease. J. Immunol. 162, 948-956 (1999). This study describes genetic linkage analyses for mice with heritable susceptibility to Lyme arthritis. It shows that arthritis consists of independent traits, such as swelling and leukocytic infiltrates, each with multigenic control.
57. Roper, R. J. et al. Genetic control of susceptibility to experimental Lyme arthritis is polygenic and exhibits consistent linkage to multiple loci on chromosome 5 in four independent mouse crosses. Genes Immun. 2, 388-397 (2001).
58. Brown, C. R. & Reiner, S. L. Genetic control of experimental Lyme arthritis in the absence of specific immunity. Infect. Immun. 67, 1967-1973 (1999). This paper shows conclusively that spirochete expansion is controlled by adaptive T- and B-cell immune responses, whereas arthritis is controlled by innate immune factors that differ between C3H and C57BL/6 mouse strains.
59. McKisic, M. D. & Barthold, S. W. T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of Lyme disease. Infect. Immun. 68, 5190-5197 (2000).
60. McKisic, M. D., Redmond, W. L. & Barthold, S. W. Cutting edge: T cell-mediated pathology in murine Lyme borreliosis. J. Immunol. 164, 6096-6099 (2000).
61. Barthold, S. W. & de Souza, M. Exacerbation of Lyme arthritis in beige mice. J. Infect. Dis. 172, 778-784 (1995).
62. Brown, J. P., Zachary, J. F., Teuscher, C., Weis, J. J. & Wooten, R. M. Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense. Infect. Immun. 67, 5142-5150 (1999).
63. H2 responses and increased Lyme arthritis. J. Infect. Dis. 178, 1512-1515 (1998).
64. Radolf, J. D. et al. Treponerna pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J. Immunol. 154, 2866-2877 (1995).
65. Erdile, L. P. et al. Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect. Immun. 61, 81-90 (1993).
66. Fikrig, E., Barthold, S. W., Kantor, F. S. & Flavell, R. A. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 250, 553-556 (1990).
67. Nguyen, T. P. et al. Partial destruction of Borrelia burgdorferi within ticks that engorged on OspE- or OspF-immunized mice. Infect. Immun. 62, 2079-2084 (1994).
68. + T cells. J. Immunol. 159, 5682-5686 (1997).
69. Fikrig, E. et al. Protective antibodies in murine Lyme disease arise independently of CD40 ligand. J. Immunol. 157, 1-3 (1996).
70. McKisic, M. D. & Barthold, S. W. T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of Lyme disease. Infect. Immun. 68, 5190-5197 (2000).
71. Fikrig, E. et al. Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity. Immunity 6, 531-539 (1997).
72. Hanson, M. S. et al. Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection. Infect. Immun. 66, 2143-2153 (1998).
73. Feng, S., Hodzic, E. & Barthold, S. W. Lyme arthritis resolution with antiserum to a 37-kilodalton Borrelia burgdorferi protein. Infect. Immun. 68, 4169-4173 (2000). This study identifies a single B. burgdorferi protein (Arp1) that induces an antibody response, which reduces the severity of arthritis in mice despite ongoing infection.
74. Keane-Myers, A. & Nickell, S. P. T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice. J. Immunol. 154, 1770-1776 (1995).
75. H2 immune responses in a murine Lyme disease model. Infect. Immun. 65, 5334-5337 (1997).
76. H2 cytokine response in Lyme disease-susceptible (C3H/HeJ) mice but not in disease-resistant (BALB/c) mice. Infect. Immun. 65, 3100-3106 (1997).
77. Kang, I., Barthold, S. W., Persing, D. H. & Bockenstedt, L. K. T-helper-cell cytokines in the early evolution of murine Lyme arthritis. Infect. Immun. 65, 3107-3111 (1997).
78. Schaible, U. E. et al. Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver. Am. J. Pathol. 137, 811-820 (1990).
79. Barthold, S. W., Sidman, C. L. & Smith, A. L. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am. J. Trop. Med. Hyg. 47, 605-613 (1992).
80. Lawson, J. P. & Steere, A. C. Lyme arthritis: radiographic findings. Radiology 154, 37-43 (1985).
81. Dattwyler, R. J., Halperin, J. J., Volkman D. J. & Luft, B. J. Treatment of late Lyme borreliosis - randomized comparison of ceftriaxone and penicillin. Lancet 1, 1191-1194 (1988).
82. Malawista, S. E. Resolution of Lyme arthritis, acute or prolonged: a new look. Inflammation 24, 493-504 (2000).
83. Girschick, H. J., Huppertz, H. I., Rüssmann, H., Krenn, V. & Karch, H. Intracellular persistence of Borrelia burgdorferi in human synovial cells. Rheumatol. Internatl 16, 125-132 (1996).
84. Franz, J. K. et al. Insights from a novel three-dimensional in vitro model of Lyme arthritis. Arthritis Rheum. 44, 151-162 (2001).
85. Fikrig, E. et al. An OspA frame shift, identified from DNA in Lyme arthritis synovial fluid, results in an outer surface protein A that does not bind protective antibodies. J. Immunol. 155, 5700-5704 (1995).
86. Kalish, R. A., Leong, J. M. & Steere, A. C. Association of treatment resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect. Immun. 61, 2774-2779 (1993).
87. Priem, S. et al. Detection of Borrelia burgdoferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy. Ann. Rheum. Dis. 57, 118-121 (1998). This article shows that B. burgdorferi DNA might sometimes be detected in synovial tissue after it is no longer found in joint fluid.
88. Carlson, D. et al. Lack of Borrelia burgdorferi DNA in synovial samples in patients with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum. 42, 2705-2709 (1999).
89. Bockenstedt, L. K., Mao, J., Hodzic, E., Barthold, S. W. & Fish, D. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment. J. Infect. Dis. 186, 1430-1437 (2002).
90. Gondolf, K. B., Mihatsch, M., Curschellas, E., Dunn J. J. & Batsford, S. R. Induction of experimental allergic arthritis with outer surface proteins of Borrelia burgdorferi. Arthritis Rheum. 37, 1070-1077 (1994).
91. Steere, A. C., Dwyer, E. & Winchester, R. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N. Engl. J. Med. 323, 219-223 (1990).
92. Steere, A. C. et al. Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum. 48, 534-540 (2003). This study shows that the strength of binding of OspA peptides to HLA-DR molecules correlates with the frequency of these H LA-DR alleles in patients with treatment-resistant Lyme arthritis.
93. Gregerson, P. K., Silver, J. & Winchester, R. J. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30, 1205-1213 (1987).
94. Weyand, C. M., McCarthy, T. G. & Goronzy, J. J. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann. Intern. Med. 117, 801-806 (1992).
95. Nepom, B. S. & Glass, D. N. Juvenile rheumatoid arthritis and HLA: report of the Park City III workshop. J. Rheumatol. Suppl. 33, 70-74 (1992).
96. Reimers, C. D., Neubert, U., Krisoferitsch, W., Pfluger, K. H. & Mayr, W. R. Borrelia burgdorferi infection in Europe: an HLA-related disease? Infection 20, 197-200 (1992).
97. Kalish, R. A., Leong, J. M. & Steere, A. C. Early and late antibody responses to full-length and truncated constructs of outer-surface protein A of Borrelia burgdorferi in Lyme disease. Infect. Immun. 63, 2228-2235 (1995).
98. Lengl-Janssen, B., Strauss, A. F., Steere, A. C. & Kamradt, T. The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A (OspA) in patients with treatment-resistant or treatment-responsive Lyme arthritis. J. Exp. Med. 180, 2069-2078 (1994).
99. Chen, J. et al. Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer-surface protein A (OspA) of Borrelia burgdorferi. Arthritis Rheum. 42, 1813-1822 (1999). This study links T-cell responses to dominant epitopes of OspA with treatment-resistant Lyme arthritis.
100. Crowley, H. & Huber, B. T. Host-adapted Borrelia burgdorferi in mice expresses OspA during inflammation. Infect. Immun. 71, 4003-4010 (2003).
101. Olsson, I., Asbrink, E., Von Stedingk, M. & Von Stedingk, L. V. Changes in Borrelia burgdorferi-specific serum IgG antibody levels in patients treated for acrodermatitis chronica atrophicans. Acta Derm. Venereol. 74, 424-428 (1994).
102. Gross, D. M. et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 281, 703-706 (1998). This is the original study that presents the concept of molecular mimicry in patients with treatment-resistant Lyme arthritis.
103. Steere, A. C., Gross, D., Meyer, A. L. & Huber, B. T. Autoimmune mechanisms in antibiotic treatment-resistant Lyme arthritis. J. Autoimmun. 16, 263-268 (2001).
104. + T cells ex vivo by using MHC class II tetramers. Proc. Natl Acad. Sci. USA 97, 11433-11438 (2000).
105. Limbach, F. X. et al. Treatment resistant Lyme arthritis caused by Borrelia garinii. Ann. Rheum. Dis. 60, 284-286 (2001).
106. Firestein, G. S. Evolving concepts of rheumatoid arthritis. Nature 423, 356-361 (2003).
107. Firestein, G. S. & Zvaifler, N. J. How important are T cells in chronic rheumatoid synovitis. Arthritis Rheum. 46, 298-308 (2002).
108. L is a partial agonist for outer surface protein A-reactive T cells. J. Immunol. 166, 5286-5291 (2001). This study presents data that concern the concept of molecular mimicry in patients with treatment-resistant Lyme arthritis.
109. Kalish, R. S. et al. Human T lymphocyte response to Borrelia burgdorferi infection: no correlation between human leukocyte function antigen type 1 peptide response and clinical status. J. Infect. Dis. 187, 102-108 (2003).
110. Maier, B. et al. Multiple cross-reactive self-ligands for Borrelia burgdorferi-specific HLA-DR4-restricted T cells. Eur. J. Immunol. 30, 448-457 (2000).
111. Benoist, C. & Mathis, D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nature Immunol. 2, 797-801 (2001). This article explores several mechanisms by which infection might trigger autoimmunity including T-cell epitope mimicry and bystander activation of autoreactive T cells.
112. Johnston, Y. E. et al. Lyme arthritis: spirochetes found in synovial microangiopathic lesions. Am. J. Pathol. 118, 26-34 (1985)
113. Steere, A. C., Duray, P. H. & Butcher, E. C. Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis: comparison with rheumatoid synovium and tonsillar lymphoid tissue. Arthritis Rheum. 31, 487-495 (1988).
114. Akin, E., Aversa, J. & Steere, A. C. Expression of adhesion molecules in synovia of patients with treatment-resistant Lyme arthritis. Infect. Immun. 69, 1774-1780 (2001).
115. Harjacek, M. et al. Prominent expression of mRNA for proinflammatory cytokines in synovium in patients with juvenile rheumatoid arthritis or chronic Lyme arthritis. J. Rheumatol. 27, 497-503 (2000).
116. Lin, B. et al. Differences in synovial fluid levels of matrix metalloproteinases suggest separate mechanisms of pathogenesis in Lyme arthritis before and after antibiotic treatment. J. Infect. Dis. 184, 174-180 (2001).
117. Matsumoto, I., Staub, A., Benoist, C. & Mathis, D. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286, 1732-1735 (1999).